Intersect ENT Analysis
| XENTDelisted Stock | USD 28.24 0.00 0.00% |
Intersect ENT is overvalued with Real Value of 23.82 and Hype Value of 28.24. The main objective of Intersect ENT delisted stock analysis is to determine its intrinsic value, which is an estimate of what Intersect ENT is worth, separate from its market price. There are two main types of Intersect ENT's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Intersect ENT's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Intersect ENT's stock to identify patterns and trends that may indicate its future price movements.
The Intersect ENT stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Intersect ENT is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Intersect Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Intersect ENT's ongoing operational relationships across important fundamental and technical indicators.
Intersect |
Intersect Stock Analysis Notes
About 92.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 2.68. Intersect ENT had not issued any dividends in recent years. The entity had 1:4 split on the 11th of July 2014. Intersect ENT, Inc. operates as an ear, nose, and throat medical technology company in the United States. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California. Intersect Ent operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 406 people. For more information please call Lisa Earnhardt at 650 641-2100 or visit www.intersectent.com.Intersect ENT Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Intersect ENT's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Intersect ENT or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Intersect ENT is not yet fully synchronised with the market data | |
| Intersect ENT has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 104.31 M. Net Loss for the year was (88.68 M) with profit before overhead, payroll, taxes, and interest of 57.15 M. | |
| Intersect ENT currently holds about 81 M in cash with (54.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.42. | |
| Over 92.0% of the company outstanding shares are owned by institutional investors |
Intersect Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 944.96 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Intersect ENT's market, we take the total number of its shares issued and multiply it by Intersect ENT's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Intersect Profitablity
Intersect ENT's profitability indicators refer to fundamental financial ratios that showcase Intersect ENT's ability to generate income relative to its revenue or operating costs. If, let's say, Intersect ENT is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Intersect ENT's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Intersect ENT's profitability requires more research than a typical breakdown of Intersect ENT's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (85.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (54.81) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $54.81.
About Intersect Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Intersect ENT prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Intersect shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Intersect ENT. By using and applying Intersect Stock analysis, traders can create a robust methodology for identifying Intersect entry and exit points for their positions.
Intersect ENT, Inc. operates as an ear, nose, and throat medical technology company in the United States. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California. Intersect Ent operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 406 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Intersect ENT to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Intersect Stock
If you are still planning to invest in Intersect ENT check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intersect ENT's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |